Alaunos Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Other Noncurrent Assets of -$500.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2024-04-01
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-12-31 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-09-30 was -$500.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-06-30 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-03-31 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$500.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$131.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was -$201.00K, a 131.65% decline from fiscal 2020.
- Alaunos Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2020 was $635.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed | Increase (Decrease) in Other Noncurrent Assets 85 month | Increase (Decrease) in Other Noncurrent Assets 94 month | Increase (Decrease) in Other Noncurrent Assets 97 month | Increase (Decrease) in Other Noncurrent Assets 100 month | Increase (Decrease) in Other Noncurrent Assets 103 month | Increase (Decrease) in Other Noncurrent Assets 106 month | Increase (Decrease) in Other Noncurrent Assets 109 month | Increase (Decrease) in Other Noncurrent Assets 112 month | Increase (Decrease) in Other Noncurrent Assets 115 month | Increase (Decrease) in Other Noncurrent Assets 118 month | Increase (Decrease) in Other Noncurrent Assets 121 month | Increase (Decrease) in Other Noncurrent Assets 124 month | Increase (Decrease) in Other Noncurrent Assets 127 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$500.00K derived: sum of 2 quarters · filed 2024-04-01 | -$500.00K derived: sum of 3 quarters · filed 2024-04-01 | -$500.00K 10-K · filed 2024-04-01 | |||||||||||||||
| 2023-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$500.00K derived: sum of 2 quarters · filed 2023-11-14 | -$500.00K 10-Q · filed 2023-11-14 | -$500.00K derived: sum of 4 quarters · filed 2024-04-01 | |||||||||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $0.00 derived: sum of 4 quarters · filed 2024-04-01 | |||||||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | -$126.00K derived: sum of 4 quarters · filed 2024-04-01 | |||||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | -$126.00K derived: sum of 3 quarters · filed 2024-04-01 | -$131.00K 10-K · filed 2024-04-01 | |||||||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$126.00K derived: sum of 2 quarters · filed 2023-11-14 | -$131.00K 10-Q · filed 2023-11-14 | $176.00K derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$131.00K 10-Q · filed 2023-08-14 | $176.00K derived: sum of 3 quarters · filed 2023-08-14 | $161.00K derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||||
| 2022-03-31 | -$5.00K 10-Q · filed 2023-05-10 | $302.00K derived: sum of 2 quarters · filed 2023-05-10 | $287.00K derived: sum of 3 quarters · filed 2023-05-10 | $353.00K derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2021-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $292.00K derived: sum of 2 quarters · filed 2023-03-07 | $358.00K derived: sum of 3 quarters · filed 2023-03-07 | -$201.00K 10-K · filed 2023-03-07 | |||||||||||||||
| 2021-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $51.00K derived: sum of 2 quarters · filed 2022-11-14 | -$508.00K 10-Q · filed 2022-11-14 | -$509.00K derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2021-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$493.00K 10-Q · filed 2022-08-15 | -$494.00K derived: sum of 3 quarters · filed 2022-08-15 | -$492.00K derived: sum of 4 quarters · filed 2022-08-15 | |||||||||||||||
| 2021-03-31 | -$559.00K 10-Q · filed 2022-05-16 | -$560.00K derived: sum of 2 quarters · filed 2022-05-16 | -$558.00K derived: sum of 3 quarters · filed 2022-05-16 | -$480.00K derived: sum of 4 quarters · filed 2022-05-16 | |||||||||||||||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.00K derived: sum of 2 quarters · filed 2022-03-30 | $79.00K derived: sum of 3 quarters · filed 2022-03-30 | $635.00K 10-K · filed 2022-03-30 | |||||||||||||||
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $80.00K derived: sum of 2 quarters · filed 2021-11-08 | $636.00K 10-Q · filed 2021-11-08 | $637.00K derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||||||
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $634.00K 10-Q · filed 2021-08-13 | $635.00K derived: sum of 3 quarters · filed 2021-08-13 | -$4.13M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||||||||
| 2020-03-31 | $556.00K 10-Q · filed 2021-05-06 | $557.00K derived: sum of 2 quarters · filed 2021-05-06 | -$4.20M derived: sum of 3 quarters · filed 2021-05-06 | -$6.06M derived: sum of 4 quarters · filed 2021-05-06 | |||||||||||||||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$4.76M derived: sum of 2 quarters · filed 2021-03-01 | -$6.61M derived: sum of 3 quarters · filed 2021-03-01 | -$9.43M 10-K · filed 2021-03-01 | |||||||||||||||
| 2019-09-30 | -$4.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$6.62M derived: sum of 2 quarters · filed 2020-11-05 | -$9.43M 10-Q · filed 2020-11-05 | -$18.06M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2019-06-30 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$4.67M 10-Q · filed 2020-08-06 | -$13.30M derived: sum of 3 quarters · filed 2021-03-01 | -$17.06M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2019-03-31 | -$2.82M 10-Q · filed 2020-05-07 | -$11.44M derived: sum of 2 quarters · filed 2021-03-01 | -$15.21M derived: sum of 3 quarters · filed 2021-03-01 | -$7.25M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2018-12-31 | -$8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$12.39M derived: sum of 2 quarters · filed 2021-03-01 | -$4.43M derived: sum of 3 quarters · filed 2021-03-01 | -$3.94M 10-K · filed 2021-03-01 | |||||||||||||||
| 2018-09-30 | -$3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.19M derived: sum of 2 quarters · filed 2019-11-07 | $4.68M 10-Q · filed 2019-11-07 | $17.67M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||||
| 2018-06-30 | $7.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $8.45M 10-Q · filed 2019-08-08 | $21.43M derived: sum of 3 quarters · filed 2020-03-02 | ||||||||||||||||
| 2018-03-31 | $490.00K 10-Q · filed 2019-05-08 | $13.48M derived: sum of 2 quarters · filed 2020-03-02 | |||||||||||||||||
| 2017-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $12.99M 10-K · filed 2020-03-02 | |||||||||||||||||
| 2017-09-30 | $3.00K 10-Q · filed 2018-11-09 | ||||||||||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$6.00K derived: sum of 2 quarters · filed 2017-11-06 | -$1.00K 10-Q · filed 2017-11-06 | ||||||||||||||||
| 2016-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$1.00K 10-Q · filed 2017-07-31 | |||||||||||||||||
| 2016-03-31 | $5.00K 10-Q · filed 2017-05-01 | ||||||||||||||||||
| 2015-12-31 | $3.00K 10-K · filed 2018-03-01 | ||||||||||||||||||
| 2015-06-30 | $18.00K 10-Q · filed 2016-08-09 | ||||||||||||||||||
| 2014-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$22.00K derived: sum of 2 quarters · filed 2017-02-16 | -$26.00K derived: sum of 3 quarters · filed 2017-02-16 | -$37.00K 10-K · filed 2017-02-16 | |||||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$4.00K derived: sum of 2 quarters · filed 2015-11-02 | -$15.00K 10-Q · filed 2015-11-02 | -$230.00K derived: sum of 4 quarters · filed 2016-02-24 | |||||||||||||||
| 2014-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$15.00K 10-Q · filed 2015-08-10 | -$230.00K derived: sum of 3 quarters · filed 2016-02-24 | -$223.00K derived: sum of 4 quarters · filed 2016-02-24 | |||||||||||||||
| 2014-03-31 | -$11.00K 10-Q · filed 2015-05-07 | -$226.00K derived: sum of 2 quarters · filed 2016-02-24 | -$219.00K derived: sum of 3 quarters · filed 2016-02-24 | -$230.00K derived: sum of 4 quarters · filed 2016-02-24 | $517.00K 10-Q · filed 2014-05-08 | ||||||||||||||
| 2013-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$208.00K derived: sum of 2 quarters · filed 2016-02-24 | -$219.00K derived: sum of 3 quarters · filed 2016-02-24 | -$477.00K 10-K · filed 2016-02-24 | -$473.00K 10-K · filed 2014-03-03 | $528.00K 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$4.00K derived: sum of 2 quarters · filed 2014-10-30 | -$262.00K 10-Q · filed 2014-10-30 | -$79.00K derived: sum of 4 quarters · filed 2015-02-26 | $739.00K 10-Q · filed 2013-10-22 | ||||||||||||||
| 2013-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$269.00K 10-Q · filed 2014-08-07 | -$86.00K derived: sum of 3 quarters · filed 2015-02-26 | -$92.00K derived: sum of 4 quarters · filed 2015-02-26 | $732.00K 10-Q · filed 2013-08-08 | ||||||||||||||
| 2013-03-31 | -$258.00K 10-Q · filed 2014-05-08 | -$75.00K derived: sum of 2 quarters · filed 2015-02-26 | -$81.00K derived: sum of 3 quarters · filed 2015-02-26 | -$51.00K derived: sum of 4 quarters · filed 2015-02-26 | $743.00K 10-Q · filed 2013-05-07 | ||||||||||||||
| 2012-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $177.00K derived: sum of 2 quarters · filed 2015-02-26 | $207.00K derived: sum of 3 quarters · filed 2015-02-26 | $230.00K 10-K · filed 2015-02-26 | $1.00M 10-K · filed 2013-03-18 | ||||||||||||||
| 2012-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $24.00K derived: sum of 2 quarters · filed 2013-10-22 | $47.00K 10-Q · filed 2013-10-22 | -$47.00K 10-Q · filed 2012-11-08 | $972.00K derived: sum of 4 quarters · filed 2014-03-03 | -$818.00K 10-Q · filed 2012-11-08 | |||||||||||||
| 2012-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $53.00K 10-Q · filed 2013-08-08 | $978.00K derived: sum of 3 quarters · filed 2014-03-03 | -$59.00K derived: sum of 4 quarters · filed 2014-03-03 | $824.00K 10-Q/A · filed 2012-08-28 | ||||||||||||||
| 2012-03-31 | $23.00K 10-Q · filed 2013-05-07 | $948.00K derived: sum of 2 quarters · filed 2014-03-03 | -$89.00K derived: sum of 3 quarters · filed 2014-03-03 | $437.00K derived: sum of 4 quarters · filed 2014-03-03 | $794.00K 10-Q · filed 2012-05-03 | ||||||||||||||
| 2011-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$112.00K derived: sum of 2 quarters · filed 2014-03-03 | $414.00K derived: sum of 3 quarters · filed 2014-03-03 | $407.00K 10-K · filed 2014-03-03 | $771.00K 10-K · filed 2012-02-29 | ||||||||||||||
| 2011-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | -$511.00K derived: sum of 2 quarters · filed 2012-11-08 | -$518.00K 10-Q · filed 2012-11-08 | $518.00K 10-Q · filed 2011-11-03 | -$463.00K derived: sum of 4 quarters · filed 2013-03-18 | $882.00K 10-Q · filed 2011-11-03 | |||||||||||||
| 2011-06-30 | $526.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28 | $519.00K 10-Q/A · filed 2012-08-28 | $574.00K derived: sum of 3 quarters · filed 2013-03-18 | $671.00K derived: sum of 4 quarters · filed 2013-03-18 | $883.00K 10-Q/A · filed 2011-08-09 | ||||||||||||||
| 2011-03-31 | -$7.00K 10-Q · filed 2012-05-03 | $48.00K derived: sum of 2 quarters · filed 2013-03-18 | $145.00K derived: sum of 3 quarters · filed 2013-03-18 | ||||||||||||||||
| 2010-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $152.00K derived: sum of 2 quarters · filed 2013-03-18 | $122.00K 10-K · filed 2013-03-18 | ||||||||||||||||
| 2010-09-30 | $97.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-03 | $67.00K 10-Q · filed 2011-11-03 | $310.00K 10-Q · filed 2011-08-01 | ||||||||||||||||
| 2010-06-30 | -$30.00K 10-Q/A · filed 2011-08-09 | ||||||||||||||||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$49.00K 10-K · filed 2012-02-29 | |||||||||||||||||
| 2009-09-30 | -$49.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |